Replies to post #812 on Cell Genesys, Inc. (CEGE)

[frans]

CEGE need to trade min at 1$ for Nasdaq listing

[manny t]

CEGE,

I am hoping that the 10% owner believes that CEGE can monetize their prostate cancer drug now that DNDN's drug has shown greater life extention.

I am hoping for some PR by the company.

Manny